-
Sino Medical Sciences Technology Secures Marketing Approval in Peru for HT Supreme Stent System
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading Chinese medical technology company, has announced that it has received marketing approval in Peru for its HT Supreme drug-eluting stent system. This approval allows the use of the system to improve the diameter of the coronary artery lumen in symptomatic heart…
-
Sino Medical Reports Five-Year PIONEER Study Results for HT Supreme Stent System
•
Sino Medical Sciences Technology Inc. (SHA: 688108), based in China, has announced the five-year follow-up results from the Phase III PIONEER study for its first-in-class HT Supreme drug-eluting stent system across the United States, Japan, and Europe. The HT Supreme system represents a significant milestone as the first cardiac stent…
-
Sino Medical Sciences Technology Secures Marketing Approval for Coronary Balloon Dilation Catheter in Morocco
•
Sino Medical Sciences Technology Inc., (SHA: 688108) a China-based medical device company, has announced that it has received marketing approval in Morocco for its SC HONKYTONK coronary balloon dilation catheter. This product, designed for balloon catheter dilation of narrowed segments or bridging sites in coronary arteries to enhance myocardial perfusion,…
-
Sino Medical Sciences Secures NMPA Nod for Balloon Guided Catheter to Aid Vascular Procedures
•
China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its balloon guided catheter. The device is designed to assist in the insertion of intravascular catheters and guide them into the target vessel within the peripheral…
-
Sino Medical Sciences Secures Hong Kong Approval for Coronary Balloon Dilation Catheter
•
HONG KONG—Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in China, has announced that it has received marketing approval in Hong Kong for its SC HONKYTONK coronary balloon dilation catheter. This approval marks a significant expansion of the product’s reach, as it is already registered…
-
Sino Medical Secures Moroccan Approvals for NC Rockstar Catheter and HT Supreme Stent System
•
Sino Medical Sciences Technology Inc. (SHA: 688108), a prominent player in China’s medical device sector, has secured marketing approvals in Morocco for its NC Rockstar non-compliant coronary artery balloon dilation catheter and the HT Supreme drug-eluting stent system. The NC Rockstar catheter is designed for balloon dilation of autologous coronary…
-
Sino Medical Sciences’ HT Supreme Drug-Eluting Stent System Gains Market Approval in Mexico
•
Sino Medical Sciences Technology Inc. (SHA: 688108), a prominent player in the medical device industry in China, has announced that its HT Supreme drug-eluting stent system has received marketing approval in Mexico. This development marks a significant expansion of the company’s global footprint. The HT Supreme system is a state-of-the-art…
-
Sino Medical Sciences’ Innovative Drug-Coated Stent System Accepted for NMPA Review
•
Sino Medical Sciences Technology Inc. (SHA: 688108), a China-based medical technology company, has announced that the National Medical Products Administration (NMPA) has accepted for review its marketing approval filing for a self-expanding intracranial drug-coated stent system. Designed for the treatment of intracranial atherosclerotic stenosis, the product is intended to support…
-
Sino Medical Sciences Secures South Korean Approvals for Three Cardiovascular Devices
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading Chinese medical device company, has announced that it has received marketing approvals from South Korean regulatory authorities for three of its cardiovascular products: the HT Supreme drug-eluting stent, the NC ROCKSTAR non-compliant balloon dilation catheter, and the SC HONKYTONK coronary balloon…
-
Sino Medical Sciences Gains Pakistani Nod for SC HONKYTONK and NC ROCKSTAR Catheters
•
Sino Medical Sciences Technology Inc., (SHA: 688108) a Chinese medical device company, has announced that it has received marketing approvals in Pakistan for two of its cardiovascular products: the SC HONKYTONK coronary balloon dilation catheter and the NC ROCKSTAR non-compliant balloon dilation catheter. These approvals mark a further expansion into…
-
Sino Medical Sciences Receives Hong Kong Approval for HT Supreme Drug-Eluting Stent System
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical technology company, has announced that it has received marketing approval in Hong Kong for its HT Supreme drug-eluting stent system. The system is now approved for use in symptomatic heart disease patients to improve the coronary artery lumen diameter caused…
-
Sino Medical Sciences’ HT Supreme Drug-Eluting Stent System Gains Market Approval in Bangladesh
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical device company, has announced that it has received market approval in Bangladesh for its HT Supreme drug-eluting stent system. The system is designed to improve the diameter of the coronary artery lumen in patients with symptomatic heart disease caused by…
-
Sino Medical Secures Approvals for Key Coronary Devices in Taiwan, India, and Uzbekistan
•
Sino Medical Sciences Technology Inc. (SHA: 688108), a China-based medical device company, has announced that it has received market approvals in Taiwan, India, and Uzbekistan for its SC HONKYTONK coronary artery balloon dilation catheter, NC Rockstar non-compliant coronary artery balloon dilation catheter, and HT Supreme drug-eluting stent system. The NC…
-
Sino Medical Sciences Secures Market Approvals in Hong Kong, China, and Malaysia for Medical Devices
•
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced receiving market approvals for two of its medical devices in Hong Kong, China, and Malaysia. The NC Rockstar non compliant coronary artery balloon dilation catheter has been approved in Hong Kong and China, while the HT Supreme drug eluting stent…
-
Sino Medical Secures Market Approval in Taiwan for NC Rockstar Coronary Catheter
•
Sino Medical Sciences Technology Inc. (SHA: 688108) has announced that its NC Rockstar non-compliant coronary artery balloon dilation catheter has received market approval in Taiwan, China. This innovative device, which includes a TIP head, balloon protective sheath, balloon, and inner tube, is designed for balloon catheter dilation of autologous coronary…
-
Sino Medical Sciences Technology’s HT Supreme Stent Gains Brazilian Market Approval
•
Sino Medical Sciences Technology Inc., (SHA: 688108) a leading China-based medical device company, has announced that its HT Supreme drug-eluting stent system has received market approval in Brazil. This system is designed to improve the diameter of the coronary artery lumen in patients suffering from symptomatic heart disease caused by…
-
Sino Medical Sciences Technology Secures EU MDR Approval for HT Supreme Drug-Eluting Stent System
•
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced that it has received Medical Device Regulation (MDR) approval in the European Union for its HT Supreme drug-eluting stent system. Features of the HT Supreme Drug-Coated Coronary Artery Stent SystemThe HT Supreme drug-coated coronary artery stent system is a combination…
-
Sino Medical Sciences Technology Secures TFDA Approval for HT Supreme Drug-Eluting Stent System
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a Chinese medical technology company, has announced that it has received market approval from the Taiwan Food and Drug Administration (TFDA) for its HT Supreme drug-eluting stent system. This significant milestone marks the company’s expansion into the Taiwan market with a cutting-edge drug-device…
-
Sino Medical Sciences’ HT Supreme Stent System Included in French Reimbursement List
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in China, announced that its HT Supreme drug-eluting stent system has been included in the reimbursement drug list (RDL) in France, effective as of October 4, 2023. This inclusion marks a significant milestone for the company’s efforts…
-
Sino Medical Sciences Receives Turkish Approval for HT Supreme Drug-Eluting Stent System
•
Sino Medical Sciences Technology Inc., (SHA: 688108), a leading Chinese medical device company, has announced that it has received market approval for its HT Supreme drug-eluting stent system from the Ministry of Health in Turkey. This approval marks a significant expansion of the product’s reach and is set to benefit…
-
Sino Medical Sciences Technology to Acquire Majority Stake in US Endovascular Device Firm eLum
•
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced plans to acquire a 72.73% stake in eLum Technologies Inc., an early-stage endovascular medical device company based in California, US, for USD 20.73 million. Upon completion of the deal, eLum will become the controlling subsidiary of Sino Medical Sciences Technology.…
